Due to the quarantine, we had to cancel our annual in-person Cancer Survivorship 101 event that was planned for June, 2020. Instead, we created a series of video lectures presented here on our website and our YouTube page featuring the speakers that were to be highlighted at the event.
Scroll down to see new videos from each speaker as they are released each month, and follow the Cancer Survivorship 101, 2020 Video Playlist on YouTube to watch the series and share with others.
Thank you so much to our sponsors:
Do you have questions about the material presented in the Cancer Survivorship 101 series?
During the month that a presentation is available you can submit questions to survivorshipprogram@gmail and the speaker will email an answer to you.
Cancer Survivorship 101, 2020 – 2022 Program
July 2020
Covid Kitchen for Cancer Survivors
Maura Harrigan, MS, RD, CSO
Oncology Registered Dietician/Project Manager
Registered Dietician Nutritionist
Survivorship Clinic, Yale Cancer Center
August 2020
Current Exercise Guidelines for Cancer Survivors
Scott Capozza, PT, MSPT
Board Certified Clinical Specialist in Oncologic Physical Therapy
Smilow Cancer Hospital Adult Survivorship Clinic at Yale Cancer Center
Oncology Outpatient Rehabilitation at the St. Raphael’s Campus/YNHH
September 2020
“I Have Cancer, Why Do I Need a Primary Care Provider?”
Larissa Nekhlyudov, MD, MPH
Professor of Medicine, Harvard Medical School
Internist, Brigham and Women’s Hospital
Clinical Director, Internal Medicine, Dana-Farber Cancer Institute
October 2020
Parenting with Cancer
Julie Berrett-Abebe, PhD, LICSW
Assistant Professor, Department of Family Therapy and Social Work, Fairfield University
November 2020
Keynote Speaker: Financial Toxicity in Cancer Survivorship
Samantha Eisenstein Watson, MBA
Founder of The Samfund
Managing Director of Stewardship, Expect Miracles Foundation
December 2020
Fear and Anxiety of Cancer Recurrence
Daniel L. Hall, PhD
Assistant Professor, Harvard Medical School
Faculty, Mongan Institute Health Policy Research Center
Staff Psychologist, Massachusetts General Hospital/ Behavioral Medicine/Benson-Henry Institute/MGH Cancer Center/Cancer Survivorship Program
January 2021
Caring for a Loved One with Cancer: Let's Talk
Kelly M. Shaffer, Ph.D.
Assistant Professor, Center for Behavioral Health and Technology
Department of Psychiatry and Neurobehavioral Sciences
University of Virginia School of Medicine
February 2021
Can Botanicals Help in Cancer Survivorship?
Darshan Mehta, MD
Medical Director, Director of Medical Education, Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital
March 2021
Perspectives of Adolescents and Young Adults Undergoing Cancer Treatment and Beyond Treatment
Giselle K. Perez, PhD
Assistant Professor, Harvard Medical School
Senior Scientist, Health Policy Research Center at the Mongan Institute
Chair, Adolescent and Young Adult Oncology Clinical Health Psychologist, Massachusetts General Hospital Behavioral Medicine Service, Massachusetts General Hospital Cancer Center Survivorship Program
April 2021
“I Had Cancer, Now I Have to Worry About My Heart?”
Anju Nohria, MD, MSc
Assistant Professor, Harvard Medical School
Director, Cardio-Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center
May 2021
“How I Became a Cancer Survivor Advocate”
Stacey Tinianov, BCPA
Patient/Community Engagement and Advocacy Consultant
June 2021
The Office of Cancer Survivorship of the National Institute of Health and How it Can Help Cancer Survivors in Our Community
Emily Tonorezos MD, MPH
Director of the Office of Cancer Survivorship
Division of Cancer Control and Population Sciences
National Institutes of Health
July 2021
Post Traumatic Stress in Cancer Survivors
Lara Traeger, PhD
Assistant Professor of Psychology
Behavioral Medicine Services
Massachusetts General Hospital
August 2021
“I Have Cancer, Should I Undergo Genetic Testing?”
Huma Q. Rana MD, MPH
Clinical Director, Diviaion of Cancer Genetics and Prevention
Dana Farber Cancer Institute
September 2021
Onco-Nephrology — Taking Care of the Kidney Through Cancer Survivorship
David Ortiz-Melo, MD
Duke University Medical Center
October 2021
The Basis of Cancer Survivorship Care
Ann H. Partridge, MD, MPH
Professor of Medicine, Harvard Medical School
Founder and Director, Program for Young Women with Breast Cancer
Director, Adult Survivorship Program
Dana-Farber Cancer Institute
November 2021
Lymphedema — What Is It and What Can Be Done About It?
Cynthia Shechter, MA, OTR/L, CIMT, CLT-UE
Shechtercare
Breast Cancer and Lymphedema Rehabilitation
Emerson, New Jersey
December 2021
The Association Between Anxiety, Depression, and Lack of Social Support and Cancer Related Pain
Sarah K. Galloway, PhD
Levine Cancer Institute
Supportive Oncology Clinic
February, 2022
Survivor Guilt in Cancer Survivorship: Existential, Emotional, and Cognitive Discussions
Kimarie Knowles, LCSW-R
Department of Social Work
Memorial Sloan Kettering Cancer Center
New York, New York 10017
March, 2022
Common Endocrinology Issues Among Cancer Survivors
Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc, MRCPI
Program Director, Endocrinology Fellowship, Brigham and Women’s Hospital
Assistant Professor of Medicine, Harvard Medical School
Education Editor, New England Journal of Medicine Group
Brigham & Women’s Hospital
221 Longwood Avenue, RFB-2
Boston, MA 02115
April, 2022
Talking About Cancer: An Oncology Social Worker’s Perspective
Lauren Soules, LICSW, OSW-C
Roxy Lock, LICSW, OSW-C
Oncology Social Workers
Mass General Cancer Center at Cooley Dickinson
30 Locust Street
Northampton, MA 01060
May, 2022
Prostate Cancer Survivorship
Alicia K. Morgans, MD, MGH
Genitourinary Medical Oncologist
Medical Director, Adult Cancer Survivorship Program
Dana Farber Cancer Institute
450 Brookline Avenue, Dana 09
Boston, MA 02215
June, 2022
Metastatic Survivorship Care
Maryam B. Lustberg, MD, MPH
Associate Professor of Medicine
Chief of Breast Medical Oncology
Breast DART Leader Director
Yale Breast Center
Yale Comprehensive Cancer Center
Yale School of Medicine
300 George St, Room
132 New Haven, CT, 06511
July, 2022
What To Expect From a Survivorship Visit
Abigail Ciampa, MSN, APRN-BC
Nurse Practitioner
Adult Survivorship Clinic
Dana Farber Cancer Institute
450 Brookline Avenue, Dana 09
Boston, MA 02215
August, 2022
Better Sleep for Cancer Survivors
Eric Zhou, PhD
Division of Sleep Medicine
Assistant Professor at Harvard Medical School
Staff Psychologist, Dana-Farber Cancer Institute
450 Brookline Avenue, Dana 09
Boston, MA 02215
September, 2022
Can Technology Increase Access to Patient-Centered Survivorship Care for Prostate Cancer and Beyond
Rich Boyajian APRN, NP
DF/BWCC Department of Radiation Oncology
Virtual Prostate Cancer Clinic Founder
October, 2022
Gynecological Cancer Survivorship
Don S. Dizon, MD, FACP, FASCO (he/him)
Professor of Medicine and Professor of Surgery, Brown University, Lifespan Cancer Institute
Director, Pelvic Malignancies Program, Lifespan Cancer Institute Director, Medical Oncology, Rhode Island Hospital
Associate Director, Community Outreach and Engagement, Legoretta Cancer Center at Brown University
Founding Member, Collaboration for Outcomes using Social Media in Oncology
November, 2022
From Sexual Health to Side Effects Management
Narjust Florez (Duma), MD
Assistant Professor of Medicine at Harvard Medical School
Thoracic Medical Oncologist
Dana-Farber Cancer Institute
450 Brookline Avenue, Dana 09
Boston, MA 02215
Introduction by Jay Burton, DO
Jay Burton, DO
President Survivor Journeys®
Dr. Jay Burton has been a primary care physician with Springfield Medical Associates in the Enfield,Connecticut office since 1988. He has provided medical care for generations of local families. Dr. Burton was diagnosed with Acute Myeloid Leukemia (AML) in May 2010. He has undergone chemotherapy, total body irradiation, and a stem cell transplant as part of his cancer treatment. He has been in remission since July 2010. During and subsequent to his cancer treatment, Dr. Burton realized that cancer survivors often do not receive comprehensive primary care. Dr. Burton developed The Primary Care Cancer Survivorship Program (PCCSP) within Springfield Medical Associates to help cancer survivors coordinate and receive primary care services during and after active cancer treatment. Dr. Burton founded Survivor Journeys® because of the lack of social and emotional support services in our region for cancer survivors, their caregivers, and families.
November, 2022: From Sexual Health to Side Effects Management
Narjust Florez (Duma), MD
Assistant Professor of Medicine at Harvard Medical School
Thoracic Medical Oncologist
Dana-Farber Cancer Institute
450 Brookline Avenue, Dana 09
Boston, MA 02215
Dr. Narjust Florez is originally from Venezuela. She completed her internal medicine residency at Rutgers New Jersey Medical School and fellowship at the Mayo Clinic in Rochester, Minnesota, where she was the chief fellow from 2018 -2019.
She is the Associate Director of the Cancer Care Equity Program, a thoracic medical oncologist at the Dana-Farber Cancer Institute/Harvard Cancer Center and a Member of the Faculty at Harvard Medical School. In 2022, Dr. Florez also became the first Latina to hold an Associate Editor position in oncology as the new Associate Editor for Diversity, Equity and Inclusion at the JAMA Oncology Journal.
Dr. Florez’s clinical interests include targeted therapy for lung cancer and the care of women with lung cancer, including their unique aspects of cancer survivorship. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer.
Apart from her clinical interests in lung cancer, she is also a leading and productive researcher in cancer health disparities, gender and racial discrimination in medical education and medicine. Dr. Florez is one of the co-founders of the Twitter community #LatinasInMedicine, now composed of over 8,500 members globally. She received many awards, including the 2018 Resident of the Year Award by the National Hispanic Medical Association, 2019 the Mayo Brothers Distinguished Fellowship award, the 2020 Rising Star award by the LEAD national conference for women in hematology and oncology, and the 2021 International Association for the Study of Lung Cancer (IASLC) North America Cancer Care Team Award for outstanding clinical care.
In addition, Dr. Florez founded the Florez (formerly Duma) Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine and medical education. The laboratory long-term goals are to create a welcoming environment for medical trainees from historically underrepresented groups in medicine while improving the care of vulnerable populations.
Members of the Florez Lab are agents of change. Since its foundation, the Duma laboratory has received research funding from several national agencies, published over 30 studies and editorials. Her work has been published in journals such as the Journal of Clinical Oncology, Nature, Cancer Cell, JAMA Oncology, Lancet Oncology, Journal of the National Cancer Institute, (amongst many others), and featured in various media outlets including The New York Times, STAT News, Healio, Onclive, Vox News, Business Insider, ASCO Post, and Doximity.
Twitter: @NarjustFlorezMD
October, 2022: Gynecological Cancer Survivorship
Don S. Dizon, MD, FACP, FASCO (he/him)
Professor of Medicine and Professor of Surgery, Brown University, Lifespan Cancer Institute
Director, Pelvic Malignancies Program, Lifespan Cancer Institute Director, Medical Oncology, Rhode Island Hospital
Associate Director, Community Outreach and Engagement, Legoretta Cancer Center at Brown University
Founding Member, Collaboration for Outcomes using Social Media in Oncology
Don S. Dizon is a Professor of Medicine and Professor of Surgery at Brown University. He is a medical oncologist specializing in pelvic malignancies, survivorship particularly as it pertains to sexual health for men and women with cancer, and social media. He grew up on the Pacific Island of Guam, and completed undergraduate and medical school at the University of Rochester in New York. He trained in Internal Medicine at Yale New-Haven Hospital and completed a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in NYC. He serves as the Director of The Pelvic Malignancies Program and Director of Hematology-Oncology clinics at Lifespan Cancer Institute, Director of Medical Oncology at Rhode Island Hospital, and leads Community Outreach and Engagement for The Legoretta Cancer Center at Brown University.
He serves as Chair of Digital Engagement for SWOG Oncology Research Network and Co-Chief Medical Officer of the nonprofit, Global Cancer Institute. He is on the advisory boards of multiple nonprofits, including the Hope Foundation for Cancer Research and the LGBTQ Cancer Network. He writes an online column for the journal, The Oncologist, and for ASCO Connection. Dr. Dizon is a founding member of the Collaboration for Outcomes Using Social Media in Oncology and is active on many platforms, including Twitter, Instagram, Facebook, and TikTok. Follow him @drdonsdizon.
September, 2022: Can Technology Increase Access to Patient-Centered Survivorship Care for Prostate Cancer and Beyond
Rich Boyajian APRN, NP DF/BWCC
Department of Radiation Oncology
Virtual Prostate Cancer Clinic Founder
Rich has been working at the Dana-Farber Brigham Cancer Center since 2000 and has been a provider in the Radiation Oncology clinic treating prostate cancer since 2013.
August, 2022: Better Sleep for Cancer Survivors
Eric Zhou, PhD Division of Sleep Medicine
Assistant Professor at Harvard Medical School
Staff Psychologist, Dana-Farber Cancer Institute
450 Brookline Avenue, Dana 09
Boston, MA 02215
Dr. Eric Zhou is on faculty in the Division of Sleep Medicine and an Assistant Professor at Harvard Medical School. He serves as a Staff Psychologist at the Dana-Farber Cancer Institute. Dr. Zhou completed his post-doctoral fellowship at the Dana-Farber Cancer Institute and his pre-doctoral internship at Brown University Alpert Medical School. He received a B.Sc. (Integrated Sciences and Psychology) from the University of British Columbia and an M.S. and Ph.D. (Clinical Psychology, Health Division) from the University of Miami. His research focuses on how we can better understand and treat sleep disorders in both pediatric and adult populations, including those with chronic illnesses. Dr. Zhou's work has been funded by the National Institutes of Health, Patient-Centered Outcomes Research Institute, private foundations, and industry. His research in the field of health psychology / behavioral medicine has been published in journals such as JAMA Psychiatry, Cancer, and SLEEP. He serves on the editorial boards of Annals of Behavioral Medicine and the International Journal of Behavioral Medicine.
July, 2022: What To Expect From a Survivorship Visit
Abigail Ciampa, MSN, APRN-BC
Nurse Practitioner
Adult Survivorship Clinic
Dana Farber Cancer Institute
450 Brookline Avenue, Dana 09
Boston, MA 02215
My name is Abby Ciampa and I am a nurse practitioner in the Survivorship Clinic at Dana-Farber Cancer Institute. Throughout my 17 year career at DFCI, I have cared for patients across all disease centers. I am passionate about caring for patients at any stage of their cancer journey. As a provider in the Survivorship Clinic I feel lucky to be able to ensure that my patient’s care post-cancer remains comprehensive and complete. I attended Mount Holyoke College for my undergraduate studies and the MGH Institute of Health Professions for my graduate work. I live in the metro west area of Boston with my husband and three children.
June, 2022: Metastatic Survivorship Care
Maryam B. Lustberg, MD, MPH
Associate Professor of Medicine
Chief of Breast Medical Oncology
Breast DART Leader Director
Yale Breast Center
Yale Comprehensive Cancer Center
Yale School of Medicine
300 George St, Room
132 New Haven, CT, 06511
Maryam Lustberg MD MPH is a breast medical oncologist. She currently serves as Chief of Breast Oncology and Director of the Breast Center at Yale Cancer Center in New Haven Connecticut. She is the co-chair of Symptom Intervention for Alliance Clinical Trials and is the incoming President of MASCC, an international organization devoted to improving cancer supportive care throughout the globe. Clinically she treats men and women with all stages of breast cancer with a focus on personalizing all aspects of cancer care.
May, 2022: Prostate Cancer Survivorship
Prostate Cancer Survivorship
Alicia K. Morgans, MD, MGH
Genitourinary Medical Oncologist
Medical Director, Adult Cancer Survivorship Program
Dana Farber Cancer Institute
450 Brookline Avenue, Dana 09
Boston, MA 02215
I am a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute. As a clinician and investigator, I have expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. My research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications, and my work has been funded by grants from the Prostate Cancer Foundation and the Department of Defense. I believe in contributing to the field outside of the work I do at my institution, and have been fortunate to participate in activities that have enabled this, including the AJCC, the advanced and localized prostate cancer treatment guidelines committees of the American Urologic Association, and the cardio-oncology committee of American Heart Association. Since 2016, I have been the President of the Medical Advisory Board for ZERO, a non-profit organization dedicated to supporting education and research funding for prostate cancer research.
April, 2022: Talking About Cancer: An Oncology Social Worker’s Perspective
Lauren Soules, LICSW, OSW-C
Roxy Lock, LICSW, OSW-C
Oncology Social Workers
Mass General Cancer Center at Cooley Dickinson
30 Locust Street Northampton, MA 01060
Lauren Soules, MSW, LICSW, OSW-C
Lauren Soules holds a BA in Political Science from UMass Amherst and an MSW from Salem State University. Lauren worked as a medical social worker in home health and hospice for more than 6 years before joining the Mass General Cancer Center at Cooley Dickinson Hospital in 2019. She has enjoyed growing the Oncology Social Worker program over the last three years, increasing their presence and accessibility at the Mass General Cancer Center at Cooley Dickinson Hospital, developing new resources, and establishing relationships with foundations and cancer-centered organizations. Lauren resides in Hadley, Massachusetts with her husband and two children.
Roxy Lock, MSW, LICSW, OSW-C
Roxy began her healthcare career as a patient care coordinator at Memorial Sloan Kettering Cancer Center in New York City. Prior to joining the Mass General Cancer Center at Cooley Dickinson Hospital as an oncology social worker in 2019, Roxy was a surgical oncology and reconstructive plastic surgery social worker at New York University Langone Medical Center. Roxy holds an MSW from New York University and BA in psychology from Connecticut College. She lives in Northampton, Massachusetts with her partner and daughter.
March, 2022: Common Endocrinology Issues Among Cancer Survivors
Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc, MRCPI
Program Director, Endocrinology Fellowship, Brigham and Women’s Hospital
Assistant Professor of Medicine, Harvard Medical School
Education Editor, New England Journal of Medicine Group
Brigham & Women’s Hospital
221 Longwood Avenue, RFB-2
Boston, MA 02115
Dr. Hamnvik is a graduate of the Royal College of Surgeons in Ireland. He completed his residency and chief residency in Internal Medicine at Brigham and Women’s Hospital (BWH) in Boston, MA where he also did his Endocrinology Fellowship. He is currently the Program Director for the Endocrinology Fellowship at BWH and directs the BWH/DFCI Center for Oncoendocrinology. He is an Assistant Professor of Medicine at Harvard Medical School.
February, 2022: Survivor Guilt in Cancer Survivorship: Existential, Emotional, and Cognitive Discussions
Kimarie Knowles, LCSW-R
Department of Social Work
Memorial Sloan Kettering Cancer Center
New York, New York 10017
Kimarie Knowles is a Licensed Clinical Social Worker whose area of expertise is in cancer and bereavement support. She has worked in the field of psycho-oncology for 15 years and has extensive clinical understanding of the needs of patients and caregivers throughout the disease continuum, from initial diagnosis, through treatment, to end of life, survivorship, recurrence, chronic illness, and bereavement. Kimarie has worked with patients and families in a variety of ways, including individually in one-to-one therapy, through couples or family therapy, and through group work.
Kimarie received her bachelor's degree from the College of William and Mary and her Master’s of Social Work degree from Catholic University of America. She has advanced training certificates in Cognitive-Behavioral Therapy, psychodynamic psychotherapy, group psychotherapy, complicated grief therapy, and meaning-centered psychotherapy. Kimarie has published academic papers and presented on topics such as coping with chronic cancer, survivor guilt in cancer survivorship, coping with the fear of recurrence, and Grief, Loss and Bereavement. She has a passion for helping patients and families as they navigate the challenges of illness, loss and survivorship.
December, 2021: The Association Between Anxiety, Depression, and Lack of Social Support and Cancer Related Pain
Sarah K. Galloway, PhD
Levine Cancer Institute
Supportive Oncology Clinic
Dr. Galloway received her Ph.D. in clinical psychology from the University of Virginia. She completed her residency at the Charleston Consortium (Medical University of South Carolina and Ralph H. Johnson VA Medical Center) and her postdoctoral fellowship in Clinical Health Psychology at the Medical University of South Carolina specializing in oncology. Dr. Galloway current serves as Assistant Professor at Levine Cancer Institute where she is involved in research, clinical practice and education.
November, 2021: Lymphedema — What Is It and What Can Be Done About It?
Cynthia Shechter, MA, OTR/L, CIMT, CLT-UE
Shechtercare
Breast Cancer and Lymphedema Rehabilitation Emerson, New Jersey
Cynthia Shechter CLT-UE, IORE, MA, OTR/L, CIMT, CORE Certified Cynthia is the owner and Director of Rehabilitation at ShechterCare. She earned her master's degree in occupational therapy at New York University. She has devoted her clinical practice to breast cancer and lymphedema rehabilitation and is passionate about patient care. Cynthia has lectured on the topic of breast cancer rehabilitation and lymphedema to several cancer and lymphedema groups in the community as well as to different physicians’ groups. Her main focus is educating patients on lymphedema management and enabling them to return to their regular lifestyle.
Cynthia believes in individual patient care over "rules". Every individual deserves to be evaluated and treated based on their individual needs, lifestyle, and ability to self-manage. Not all treatment is about everything one must do, sometimes, we need to recognize the grey areas to ensure recovery - mind - body - spirit.
Cynthia is dedicated to increasing the awareness of the medical community on the benefits of rehabilitation following breast cancer surgery and has been an expert for the LE&RN "Ask the Experts" since the program began and has helped over 110 members thus far.
October, 2021: The Basis of Cancer Survivorship Care
Ann H. Partridge, MD, MPH
Professor of Medicine, Harvard Medical School
Founder and Director, Program for Young Women with Breast Cancer
Director, Adult Survivorship Program Dana-Farber Cancer Institute
Ann Partridge, MD, MPH is a Professor of Medicine at Harvard Medical School, and Vice Chair of Medical Oncology at Dana-Farber Cancer Institute, where she also serves as Director of the Adult Survivorship Program and leads the Program for Young Women with Breast Cancer. As a medical oncologist and clinical researcher, she has sought to improve the care and outcomes of patients with cancer by conducting research, and by developing innovative clinical programming. Dr. Partridge serves in leadership roles nationally and internationally including as co-chair of the Breast Committee of the Alliance for Clinical Trials in Oncology and co-chair of the biennial ESMO-ESO sponsored Breast Cancer in Young Women Conference. She also served as Chair of the Center for Disease Control and Prevention (CDC) Advisory Committee on Breast Cancer in Young Women from 2010-17.
She has received prior awards and grants including a Champions of Change award from the White House, an ASCO Improving Cancer Care Grant, the CDC Carol Friedman Award, the American Association for Cancer Research (AACR) Outstanding Investigator Award for Breast Cancer, and the Ellen L. Stovall Award in Cancer Survivorship from ASCO, and the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School. After graduating from Georgetown University, Dr. Partridge received her medical degree from Cornell University Medical College, pursued an internal medicine residency at the Hospital for the University of Pennsylvania, and completed Medical Oncology and Hematology fellowship at Dana-Farber/Partners CancerCare. She earned a Master of Public Health degree at the Harvard School of Public Health.
September, 2021: Onco-Nephrology — Taking Care of the Kidney Through Cancer Survivorship
David Ortiz-Melo, MD
Duke University Medical Center
David I. Ortiz-Melo, MD is an Assistant Professor in the Department of Medicine at Duke University. He joined the Division of Nephrology in 2014, soon after completing his Nephrology fellowship at Duke. His clinical practice focuses on management of uncontrolled high blood pressure, chronic kidney disease, acute kidney failure, and fluid and electrolyte disorders. Dr Ortiz-Melo also has particular interest in the evaluation and management of kidney diseases affecting cancer patients (onco-nephrology). He is the creator and current director of the Duke onco-nephrology clinic, which was established in 2015. He is passionate about medical education, as well as diversity, equity, and inclusion in medicine.
August, 2021: “I Have Cancer, Should I Undergo Genetic Testing?”
Huma Q. Rana MD, MPH
Clinical Director, Diviaion of Cancer Genetics and Prevention
Dana Farber Cancer Institute
Huma Q. Rana, MD, MPH is the Clinical Director of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School. At Dana-Farber and its affiliates and satellites, Dr. Rana oversees the medical management and the clinical operations that provide care to individuals with rare genetic susceptibilities to cancer. In addition to her clinical work, Dr. Rana leads multiple clinical research projects focused on developing cancer prevention and screening for those with hereditary cancer risk, and novel approaches to improving access to cancer genetics services. Dr. Rana received her medical degree from the Rutgers Robert Wood Johnson Medical School, completed her residencies in Internal Medicine and Clinical Genetics at Mount Sinai School of Medicine in New York, and received her MPH from the Harvard T.H. Chan School of Public Health. She has been a member of the Dana-Farber faculty since 2012.
July, 2021: Post Traumatic Stress in Cancer Survivors
Lara Traeger, PhD
Assistant Professor of Psychology
Behavioral Medicine Services
Massachusetts General Hospital
Lara Traeger is a licensed clinical psychologist at the Massachusetts General Hospital (MGH) Cancer Center and an Assistant Professor at Harvard Medical School. She specializes in the care of adults and their families affected by psychological distress related to cancer. Her active program of research focuses on enhancing self-efficacy, health behaviors and resilience following cancer diagnosis as well as enhancing patient-clinician collaboration. She conducts her work in collaboration with specialists in cancer, aging, behavioral medicine, mind-body medicine, decision science, and public health to support a multi-disciplinary approach to this work.
June, 2021: The Office of Cancer Survivorship of the National Institute of Health and How it Can Help Cancer Survivors in Our Community
Emily Tonorezos MD, MPH
Director of the Office of Cancer Survivorship Division of Cancer Control and Population Sciences National Institutes of Health
Emily S. Tonorezos, MD, MPH, serves as Director of the Office of Cancer Survivorship, part of the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI). In this position, Dr. Tonorezos leads NCI’s efforts to address the challenges facing cancer survivors and their families -- to prevent or mitigate adverse effects and to improve the health and well-being of cancer survivors from the time of diagnosis through the remainder of their lives. Dr. Tonorezos came to NCI from Memorial Sloan Kettering Cancer Center and the Weill Cornell Medical College, both in New York, NY, where she served as Director of the Adult Long-Term Follow-Up Program for survivors of childhood and young adult cancers. Her research focuses on cardiometabolic consequences of cancer therapy, childhood and young adult cancer survivorship, diet and nutrition, and care coordination for this population.
She has served on the National Academy of Sciences, Engineering and Medicine Committee on Childhood Cancer and Disability; the Cancer Survivorship Committee, the Adolescent and Young Adult Task Force, and the Clinical Guideline Committee for the American Society of Clinical Oncology (ASCO); and the Metabolic Syndrome Guideline Committee for the Children’s Oncology Group (COG). She is currently co-leader of the International Guideline Harmonization Group for the metabolic syndrome and led an international effort to develop recommendations for adult survivors of heritable retinoblastoma. Dr. Tonorezos is a general internist, having earned her medical degree from the University of Rochester School of Medicine and masters in public health from the Johns Hopkins Bloomberg School of Public Health. She completed internal medicine residency and chief residency at Columbia University Medical Center, as well as a general internal medicine fellowship at the Johns Hopkins Hospital.
May, 2021: “How I Became a Cancer Survivor Advocate”
Stacey Tinianov, BCPA
Patient/Community Engagement and Advocacy Consultant
Stacey Tinianov is an early stage breast cancer thriver, a board certified patient advocate, and a community engagement consultant in the San Francisco Bay area. Since her diagnosis and treatment for breast cancer, Stacey has become a vocal advocate for patient engagement and empowerment via collaborative education; community building; shared decision making; health data access; and person-centered design. When it comes to person-centered advocacy, her goal is to build bridges between science, industry, policy and communities to improve understanding and participation in both directions in order to ultimately deliver accessible, quality, person-centered care and accelerate research.
Stacey is a co-founder of Advocates for Collaborative Education (ACE); an advisor to Ciitizen, CareLoop, and Pulse for Good; an advisory board member of Camp Kesem SCU and the California Precision Medicine Consortium (CaPMC); founding member of Kaiser Santa Clara’s Member Patient Advisory Council (MPAC); a research advocate for Komen AIS and UCSF’s Breast Science Advocacy Core (BSAC); and a policy advocate for the National Coalition for Cancer Survivorship (NCCS). She is co-chair of the Patient Advisory Council for the COVID-19 and Cancer Consortium (CCC19) and an individual member of CARIN Alliance and the Palliative Care Advocacy Initiative.
April, 2021: “I Had Cancer, Now I Have to Worry About My Heart?”
Anju Nohria, MD, MSc.
Assistant Professor, Harvard Medical School
Director, Cardio-Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center
Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana Faber/Brigham and Women’s Cancer Center and is an advanced heart disease specialist at Brigham and Women’s Hospital. She is an Assistant Professor of Medicine at Harvard Medical School. Dr. Nohria received her medical degree from Harvard Medical School. She completed her residency in Internal Medicine and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at Brigham and Women’s Hospital. Dr. Nohria’s clinical activities span cardio-oncology and heart failure and transplantation. The author of over 60-peer reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications than can arise as a consequence of cancer treatment.
March, 2021: Perspectives of Adolescents and Young Adults Undergoing Cancer Treatment and Beyond Treatment
Giselle K. Perez, PhD
Assistant Professor, Harvard Medical School
Senior Scientist, Health Policy Research Center at the Mongan Institute
Chair, Adolescent and Young Adult Oncology Clinical Health Psychologist, Massachusetts General Hospital
Behavioral Medicine Service, Massachusetts General Hospital Cancer Center Survivorship Program
Giselle K. Perez, PhD is an Assistant Professor at Harvard Medical School and a clinical health psychologist at the Massachusetts General Hospital. She has a strong interest in cancer survivorship and behavioral intervention research and is committed to identifying innovative solutions to improve cancer prevention, health care equity, and cancer outcomes among vulnerable, underserved and minority groups, particularly adolescents and young adults. Specific research interests include the development of behavioral and mind-body interventions to promote stress coping and improve overall physical and emotional health outcomes for patients throughout the cancer spectrum. Clinically, she specializes in working with adolescents and young adults touched by cancer with a focus on managing the unexpected social and emotional challenges that occur after cancer treatment, improving stress and anxiety symptoms, coping with uncertainty, and promoting health behavior change. In particular, her work examines the physical, psychosocial, and biobehavioral (e.g., stress hormones) effects of stress and stress interventions in cancer patients and survivors.
February 2021: Can Botanicals Help in Cancer Survivorship?
Darshan Mehta, MD
Medical Director, Director of Medical Education, Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital
Darshan Mehta, MD, MPH is Assistant Professor in Medicine at Harvard Medical School. He is the Director of Education for the Osher Center at Brigham & Women’s Hospital and Harvard Medical School, Medical Director of the Benson-Henry Institute for Mind Body Medicine at MGH, and Interim Director for the Office for Well-Being with the Center for Faculty Development at MGH. In addition, he is the MGH site director for the Practice of Medicine curriculum required of all 1st-year Harvard Medical School students, and leads their well-being curriculum. His educational and research interests include curricular development in complementary and integrative medical therapies, mind/body educational interventions in health professions training, and promotion of professionalism in medical trainees.
January 2021: "Caring for a Loved One with Cancer, Let's Talk"
Kelly M. Shaffer, Ph.D.
Assistant Professor, Center for Behavioral Health and Technology
Department of Psychiatry and Neurobehavioral Sciences
University of Virginia School of Medicine
Kelly Shaffer is an Assistant Professor in the Center for Behavioral Health and Technology at the University of Virginia School of Medicine. She is a licensed clinical psychologist, having completed training at the University of Miami, Harvard Medical School/Massachusetts General Hospital, and Memorial Sloan Kettering Cancer Center. Specializing in family caregiving and psychosocial oncology, her work examines how to modernize and expand psychosocial care to cancer caregivers through scalable and effective technology-based interventions.
December, 2020: Fear and Anxiety of Cancer Recurrence
Daniel L. Hall, PhD
Assistant Professor, Harvard Medical School
Faculty, Mongan Institute Health Policy Research Center
Staff Psychologist, Massachusetts General Hospital/ Behavioral Medicine/Benson-Henry Institute/MGH Cancer Center/Cancer Survivorship Program
Daniel L. Hall, Ph.D. is a licensed clinical health psychologist at Massachusetts General Hospital and an Assistant Professor of Psychology at Harvard Medical School. He is a faculty member of the Mongan Institute Health Policy Research Center and a core member of the MGH Behavioral Medicine Program, Benson-Henry Institute, Cancer Outcomes Research and Education (CORE) Program, and Cancer Survivorship Program. Dr. Hall’s interests include (a) uncertainty, stress, and health behaviors among adults affected by cancer and (b) the development and implementation of behavioral interventions for managing these concerns. His research is currently supported by the National Institutes of Health and the American Cancer Society. You can follow Dr. Hall @DanielHallPhD.
November, 2020: Financial Toxicity in Cancer Survivorship with Samantha Eisenstein Watson, MBA
Keynote Speaker: Samantha Eisenstein Watson, MBA
Founder of The Samfund
Managing Director of Stewardship, Expect Miracles Foundation
Samantha Watson, MBA is the Founder of The Samfund and Managing Director of Stewardship at Expect Miracles Foundation. She has been an advocate for young adult cancer survivors for almost two decades, is recognized as a thought leader in the fields of young adult cancer and financial toxicity, and is a current member of ASCO's Cancer Survivorship Committee. She created The Samfund in 2003 to support young adults as they regain their financial health after cancer; to date, The Samfund has awarded close to $2.5 million in grants to individuals across the country. In 2019, The Samfund joined forces with Expect Miracles Foundation though the grants program and commitment to young adults remain entirely intact. Sam is a two-time young adult cancer survivor, diagnosed with Ewing’s Sarcoma in December of 1999, and with secondary Myelodysplastic Syndrome in April of 2001. She underwent an allogeneic bone marrow transplant in August of 2001 and now lives outside of Boston with her husband and two children.
October, 2020: Parenting with Cancer with Julie Berrett-Abebe, PhD, LICSW
Julie Berrett-Abebe, PhD, LICSW
Assistant Professor, Department of Family Therapy and Social Work, Fairfield University
Julie Berrett-Abebe, PhD, LICSW is a social work researcher, educator, and practitioner with expertise in cancer and aging as well as interprofessional practice and education. Julie practiced clinically as an oncology social worker at Massachusetts General Hospital, where she also supervised and lectured in the student training program. With funding from the American Cancer Society, Julie completed a dissertation on interprofessional education and addressing cancer survivors’ unmet psychosocial needs. She graduated with a PhD from Simmons University in 2017. Julie is currently an Assistant Professor in the Social Work Department at Westfield State University, where she is also the training coordinator for a HRSA workforce development grant to train social workers in integrated health care. In fall 2020, Julie will be transitioning to an Assistant Professor appointment at Fairfield University.
September, 2020: "I Have Cancer, Why Do I Need a Primary Care Doctor?" with Larissa Nekhlyudov, MD, MPH
Larissa Nekhlyudov, MD, MPH
Professor, Harvard Medical School
Internist, Brigham & Women’s Hospital
Clinical Director, Internal Medicine for Cancer Survivors, Dana-Farber Cancer Institute
Larissa Nekhlyudov, MD, MPH is a board-certified general internist and Medical Director of Primary Care Associates, Longwood. Dr. Nekhlyudov received her medical degree from the Mount Sinai School of Medicine, and completed residency training at the Yale Primary Care Program. Prior to coming to the BWH, she practiced internal medicine at Harvard Vanguard Medical Associates for over 15 years. In addition to being a primary care provider, she has extensive experience in cancer-related research and education. She is particularly interested in improving the care of cancer survivors and the interplay between primary and oncology care.
August, 2020: Current Exercise Guidelines for Cancer Survivors with Scott Capozza, PT, MSPT
Scott J. Capozza, PT, MSPT
Board Certified Clinical Specialist in Oncologic Physical Therapy
Smilow Cancer Hospital Adult Survivorship Clinic at Yale Cancer Center
Oncology Outpatient Rehabilitation at the St. Raphael’s Campus/YNHH
Scott Capozza, PT, MSPT has been the physical therapist for the Smilow Cancer Hospital Survivorship Clinic at Yale Cancer Center since its inception in 2006. In this setting, he works in unison with a dietitian, social worker and physician assistant to address the late and long-term side effects of cancer treatment. Through this collaborative team approach, common survivorship themes such as cancer-related fatigue and fear of recurrence are addressed. Scott and the survivorship team presented their clinic model at the 2020 American Physical Therapy Association’s Combined Sections Meeting. Scott is also Yale New Haven Hospital’s first dedicated outpatient physical therapist in oncology rehabilitation. Scott is among the first class of board-certified clinical specialists in oncologic physical therapy in the country and also serves as a SACE II Item Writer for the oncology certification exam through the ABPTS. He currently is the Membership Chairperson for the American Physical Therapy Association’s Academy of Oncologic Physical Therapy as well as the APTA CT Chapter’s Oncology SIG co-chairperson.
July, 2020: COVID Kitchen with Maura Harrigan, MS, RD, CSO
Maura Harrigan, MS, RD, CSO
Oncology Research Registered Dietician/Project Manager
Registered Dietician Nutritionist
Adult Survivorship Clinic, Yale Cancer Center
Maura is certified in Adult Weight Management and is a Specialist in Oncology Nutrition through the Academy of Nutrition and Dietetics. As part of the multidisciplinary team of the Adult Survivorship Clinic since its inception in 2006, Maura provides the nutrition counseling to cancer survivors of all diagnoses. Maura is a frequently invited speaker addressing the unique nutrition concerns of the cancer survivor. As the Project Manager of the Lifestyle Exercise and Nutrition (LEAN) Study, Maura works with the research team of Melinda Irwin, PhD, MPH and Tara Sanft, MD and provides the nutrition and exercise intervention counseling to the breast cancer participants throughout the course of their active treatment.
